- Home
- ORKT vs GDTC Comparison
ORKT vs GDTC Comparison
Compare ORKT & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKT
- GDTC
- Stock Information
- Founded
- ORKT 2003
- GDTC 2018
- Country
- ORKT Singapore
- GDTC Singapore
- Employees
- ORKT N/A
- GDTC N/A
- Industry
- ORKT
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- ORKT
- GDTC Health Care
- Exchange
- ORKT NYSE
- GDTC Nasdaq
- Market Cap
- ORKT N/A
- GDTC 28.0M
- IPO Year
- ORKT 2024
- GDTC 2023
- Fundamental
- Price
- ORKT $0.54
- GDTC $2.17
- Analyst Decision
- ORKT Strong Buy
- GDTC Buy
- Analyst Count
- ORKT 1
- GDTC 1
- Target Price
- ORKT $5.00
- GDTC $5.00
- AVG Volume (30 Days)
- ORKT 252.6K
- GDTC 6.7K
- Earning Date
- ORKT 01-01-0001
- GDTC 01-01-0001
- Dividend Yield
- ORKT N/A
- GDTC N/A
- EPS Growth
- ORKT N/A
- GDTC N/A
- EPS
- ORKT N/A
- GDTC N/A
- Revenue
- ORKT $2,962,282.00
- GDTC $368,838.00
- Revenue This Year
- ORKT $9.63
- GDTC $5.37
- Revenue Next Year
- ORKT N/A
- GDTC N/A
- P/E Ratio
- ORKT N/A
- GDTC N/A
- Revenue Growth
- ORKT N/A
- GDTC N/A
- 52 Week Low
- ORKT $0.40
- GDTC $1.20
- 52 Week High
- ORKT $8.00
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- ORKT N/A
- GDTC 43.36
- Support Level
- ORKT N/A
- GDTC $2.04
- Resistance Level
- ORKT N/A
- GDTC $2.34
- Average True Range (ATR)
- ORKT 0.00
- GDTC 0.07
- MACD
- ORKT 0.00
- GDTC 0.01
- Stochastic Oscillator
- ORKT 0.00
- GDTC 24.24
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.